SCHEMBL14214496

SCHEMBL14214496

CC(c1ccc(O)cc1)(c1ccc(O)cc1)c1ccc(-c2ccc(OC(F)F)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 4/20 0.47
▸ ESR1 P03372 3/20 0.47
▸ DRD1 P21728 1/20 0.45
▸ KIF11 P52732 1/20 0.44
▸ PTPN5 P54829 1/20 0.41
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ ADAM17 P78536 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ TYR P14679 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ AR P10275 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ ESRRG P62508 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL755053 0.80 MEN1 (0.50) ESR2ESR1DRD1MEN1KMT2A
SCHEMBL10772499 0.80 ESR1 (0.70) ESR2ESR1KIF11MEN1KMT2A
SCHEMBL26136547 0.80 ESR1 (0.70) ESR2ESR1KIF11MEN1KMT2A
SCHEMBL12004872 0.80 ESR1 (0.70) ESR2ESR1KIF11MEN1KMT2A
SCHEMBL10774251 0.79 ESR2 (0.73) ESR2ESR1KIF11MEN1KMT2A
SCHEMBL12541779 0.79 ESR1 (0.53) ESR2ESR1PTPN5MEN1KMT2A
SCHEMBL13264261 0.75 DRD1 (0.68) DRD1MEN1KMT2AALOX15GFER
SCHEMBL23082207 0.75 ESR2 (0.63) ESR2ESR1KIF11MEN1KMT2A
SCHEMBL13906278 0.74 DRD1 (0.53) DRD1KIF11PTPN5MEN1KMT2A
SCHEMBL8254927 0.74 TP53 (0.49) DRD1MEN1KMT2AALOX15GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114183-A1 Monomers comprising superacidic groups, and polymers therefrom GENERAL ELECTRIC COMPANY (US) 2008-05-15 — — US disclosed
US-20080114149-A1 Polymers comprising superacidic groups, and uses thereof GENERAL ELECTRIC COMPANY (US) 2008-05-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114183-A1 Monomers comprising superacidic groups, and polymers therefrom DDC, ACMSD, ALKBH3 ESR2 4001/4885ESR1 1278/4885DRD1 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback